Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: LRRC superfamily expression in stromal cells predicts the clinical prognosis and platinum resistance of ovarian cancer

Fig. 2

Box diagram for LRRC15 and LRRC32 expression. Pan-cancer analysis after log2 transformation using TPM-formatted RNA-seq data from TCGA and GTEx (A) (ns, *p ≥ 0.05; **p < 0.05; ***p < 0.01). The expression of LRRC15 in HGSC tumour tissues was significantly increased, p < 0.05. The expression of LRRC32 in HGSC tumour tissues was reduced, p > 0.05 (B)

Back to article page